Metallomics for drug development: an integrated CE-ICP-MS and ICP-MS approach reveals the speciation changes for an investigational ruthenium(iii) drug bound to holo-transferrin in simulated cancer cytosol†
Abstract
A method based on combining
Maintenance work is planned from 09:00 BST to 12:00 BST on Saturday 28th September 2024.
During this time the performance of our website may be affected - searches may run slowly, some pages may be temporarily unavailable, and you may be unable to access content. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a
Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Kosygin Str. 19, 119991 Moscow, Russian Federation
E-mail:
andrei.timerbaev@univie.ac.at
Fax: +7-495-938-2054
Tel: +7-495-939-7035
b Chair of Analytical Chemistry, Warsaw University of Technology, Noakowskiego 3, 00664 Warsaw, Poland
A method based on combining
Fetching data from CrossRef.
This may take some time to load.
Loading related content